Role of telomere length in human carcinogenesis
A Tsatsakis, T Oikonomopoulou… - International …, 2023 - spandidos-publications.com
Cancer is considered the most important clinical, social and economic issue regarding
cause‑specific disability‑adjusted life years among all human pathologies. Exogenous …
cause‑specific disability‑adjusted life years among all human pathologies. Exogenous …
[HTML][HTML] Glycogen storage diseases: An update
E Gümüş, H Özen - World Journal of Gastroenterology, 2023 - ncbi.nlm.nih.gov
Glycogen storage diseases (GSDs), also referred to as glycogenoses, are inherited
metabolic disorders of glycogen metabolism caused by deficiency of enzymes or …
metabolic disorders of glycogen metabolism caused by deficiency of enzymes or …
Treating neutropenia and neutrophil dysfunction in glycogen storage disease type Ib with an SGLT2 inhibitor
SB Wortmann, JLK Van Hove… - Blood, The Journal …, 2020 - ashpublications.org
Neutropenia and neutrophil dysfunction cause serious infections and inflammatory bowel
disease in glycogen storage disease type Ib (GSD-Ib). Our discovery that accumulating 1, 5 …
disease in glycogen storage disease type Ib (GSD-Ib). Our discovery that accumulating 1, 5 …
Failure to eliminate a phosphorylated glucose analog leads to neutropenia in patients with G6PT and G6PC3 deficiency
M Veiga-da-Cunha, N Chevalier… - Proceedings of the …, 2019 - National Acad Sciences
Neutropenia represents an important problem in patients with genetic deficiency in either the
glucose-6-phosphate transporter of the endoplasmic reticulum (G6PT/SLC37A4) or G6PC3 …
glucose-6-phosphate transporter of the endoplasmic reticulum (G6PT/SLC37A4) or G6PC3 …
Understanding the role of SGLT2 inhibitors in glycogen storage disease type Ib: the experience of one UK centre
RK Halligan, RN Dalton, C Turner, KA Lewis… - Orphanet Journal of …, 2022 - Springer
Background Glycogen storage disease type Ib (GSD Ib) is a severe disorder of carbohydrate
metabolism due to bi-allelic variants in SLC37A4. It is associated with neutropaenia and …
metabolism due to bi-allelic variants in SLC37A4. It is associated with neutropaenia and …
Crohn disease-like enterocolitis remission after empagliflozin treatment in a child with glycogen storage disease type Ib: a case report
A Rossi, E Miele, S Fecarotta… - Italian journal of …, 2021 - Springer
Background Besides major clinical/biochemical features, neutropenia and inflammatory
bowel disease (IBD) constitute common complications of Glycogen storage disease type Ib …
bowel disease (IBD) constitute common complications of Glycogen storage disease type Ib …
Improved inflammatory bowel disease, wound healing and normal oxidative burst under treatment with empagliflozin in glycogen storage disease type Ib
SC Grünert, R Elling, B Maag, SB Wortmann… - Orphanet journal of rare …, 2020 - Springer
Background Glycogen storage disease type Ib (GSD Ib) is a rare inborn error of glycogen
metabolism due to mutations in SLC37A4. Besides a severe form of fasting intolerance, the …
metabolism due to mutations in SLC37A4. Besides a severe form of fasting intolerance, the …
Patient‐reported outcomes on empagliflozin treatment in glycogen storage disease type Ib: an international questionnaire study
SC Grünert, A Venema, J LaFreniere… - JIMD …, 2023 - Wiley Online Library
In patients with glycogen storage disease type Ib (GSD Ib), quality of life is severely
hampered by neutropenia and neutropenia‐associated symptoms. SGLT2 inhibitors are a …
hampered by neutropenia and neutropenia‐associated symptoms. SGLT2 inhibitors are a …
Neutropenia in glycogen storage disease Ib: outcomes for patients treated with granulocyte colony-stimulating factor
DC Dale, AA Bolyard, T Marrero… - Current opinion in …, 2019 - journals.lww.com
GSD Ib is a complex disorder of glucose metabolism causing severe chronic neutropenia. G-
CSF is effective to raise blood neutrophil counts and reduce fevers and infections in most …
CSF is effective to raise blood neutrophil counts and reduce fevers and infections in most …
Potential roles of telomeres and telomerase in neurodegenerative diseases
J Wang, Y Liu, Q Xia, Q Xia, B Wang, C Yang… - International journal of …, 2020 - Elsevier
Telomeres, protective DNA-protein complexes at the end of eukaryotic linear chromosomes,
play pivotal roles in the maintenance of genomic stability during cell division. When …
play pivotal roles in the maintenance of genomic stability during cell division. When …